Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Jukema

Showing results (181-190 of 202) with videos related to

Pageof 21
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|December 20, 2008
Leukocyte cathepsin S is a potent regulator of both cell and matrix turnover in advanced atherosclerosisR de Nooijer, I Bot, J H von der Thüsen, et al.
Genes and Immunity|November 24, 2006
Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary interventionP S Monraats, F A S Kurreeman, D Pons, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|March 8, 2021
The first multicentre study on coronary anomalies in the Netherlands: MuSCATC J Koppel, B W Driesen, R J de Winter, et al.
Annals of the New York Academy of Sciences|April 27, 2007
Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER studyS Trompet, D Pons, A J M DE Craen, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 7, 2021
2020 ESC Guidelines on acute coronary syndrome without ST-segment elevation : Recommendations and critical appraisal from the Dutch ACS and Interventional Cardiology working groupsF Arslan, P Damman, B Zwart, et al.
Circulation|January 19, 2005
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjectsS M Boekholdt, F M Sacks, J W Jukema, et al.
BMC Endocrine Disorders|September 21, 2018
Study protocol: a randomised controlled trial on the clinical effects of levothyroxine treatment for subclinical hypothyroidism in people aged 80 years and overR S Du Puy, I Postmus, D J Stott, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 27, 2022
The Netherlands Heart Tissue Bank : Strengthening the cardiovascular research infrastructure with an open access Cardiac Tissue RepositoryM T H M Henkens, J F van Ast, A S J M Te Riele, et al.
International Journal of Cardiology|March 8, 2024
The impact of patient-reported frailty on cardiovascular outcomes in elderly patients after non-ST-acute coronary syndromeW W A van den Broek, M E Gimbel, R S Hermanides, et al.
Plos One|May 20, 2022
Resting heart rate and incident atrial fibrillation: A stratified Mendelian randomization in the AFGen consortiumJ E Siland, B Geelhoed, C Roselli, et al.
Pageof 21

Showing results (181-190 of 202) with videos related to

Sort By:
Pageof 21
Arteriosclerosis, Thrombosis, and Vascular Biology|December 20, 2008
Leukocyte cathepsin S is a potent regulator of both cell and matrix turnover in advanced atherosclerosisR de Nooijer, I Bot, J H von der Thüsen, et al.
Genes and Immunity|November 24, 2006
Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary interventionP S Monraats, F A S Kurreeman, D Pons, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|March 8, 2021
The first multicentre study on coronary anomalies in the Netherlands: MuSCATC J Koppel, B W Driesen, R J de Winter, et al.
Annals of the New York Academy of Sciences|April 27, 2007
Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER studyS Trompet, D Pons, A J M DE Craen, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 7, 2021
2020 ESC Guidelines on acute coronary syndrome without ST-segment elevation : Recommendations and critical appraisal from the Dutch ACS and Interventional Cardiology working groupsF Arslan, P Damman, B Zwart, et al.
Circulation|January 19, 2005
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjectsS M Boekholdt, F M Sacks, J W Jukema, et al.
BMC Endocrine Disorders|September 21, 2018
Study protocol: a randomised controlled trial on the clinical effects of levothyroxine treatment for subclinical hypothyroidism in people aged 80 years and overR S Du Puy, I Postmus, D J Stott, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 27, 2022
The Netherlands Heart Tissue Bank : Strengthening the cardiovascular research infrastructure with an open access Cardiac Tissue RepositoryM T H M Henkens, J F van Ast, A S J M Te Riele, et al.
International Journal of Cardiology|March 8, 2024
The impact of patient-reported frailty on cardiovascular outcomes in elderly patients after non-ST-acute coronary syndromeW W A van den Broek, M E Gimbel, R S Hermanides, et al.
Plos One|May 20, 2022
Resting heart rate and incident atrial fibrillation: A stratified Mendelian randomization in the AFGen consortiumJ E Siland, B Geelhoed, C Roselli, et al.
Pageof 21